Cigna Corporation

🇺🇸New York Stock Exchange
Back to all articles
Cigna Corporation stock analysis CI overview
Bullish +65

Bernstein Upgrades The Cigna Group (CI) From “Market Perform” to “Outperform”

📈 Bernstein upgraded The Cigna Group (CI) from "Market Perform" to "Outperform."

💵 Analysts set a $358 price target for the stock following the upgrade.

🏥 Management reiterated its 2026 projection of at least $30.25 per share in consolidated adjusted income from operations.

💊 The company expects Evernorth's pre-tax adjusted income to be at least $6.9 billion.

🦠 Cigna Healthcare is projected to generate at least $4.5 billion in pre-tax adjusted income from operations.

📉 Analysts slightly raised EPS estimates for the years 2027 through 2030 while keeping the 2026 estimate unchanged.

⚖️ Investor confidence is driven by PBM reform, FTC settlements, announced model changes, and guided economic impacts.

👋 CEO Cordani's retirement was seen as a surprise, but analysts remain confident in new CEO Brian Evanko.

🌐 Cigna operates globally offering pharmacy benefit management, specialty pharmacy, care delivery, and medical insurance solutions.

📉 The article notes that while CI is an investment, AI stocks may offer greater upside potential with less risk.

📄 Disclosure indicates none and encourages readers to follow Insider Monkey on Google News.

Bullish Signals
  • Bernstein upgraded The Cigna Group (CI) from 'Market Perform' to 'Outperform', reflecting strong analyst confidence in the stock's prospects.
  • The firm established a $358 price target, indicating significant upside potential relative to current market prices.
  • Analysts expect the company's stock multiple to increase over time due to positive drivers such as PBM reform bill impacts and favorable economic conditions.
  • Management slightly raised EPS estimates for 2027-2030, signaling long-term growth visibility and operational stability.
  • The company reiterated its 2026 projection with an estimated consolidated adjusted income from operations of at least $30.25 per share.
  • Cigna Healthcare is projected to generate at least $4.5 billion in pre-tax adjusted income from operations for 2026, reinforcing core business strength.
  • Management maintained stability across major sectors by restating Evernorth's projection for at least $6.9 billion in pre-tax adjusted income from operations.
  • Analysts at JPMorgan Chase & Co. expressed confidence in the company's new leadership transition under CEO Brian Evanko following the departure of Cordani.
Risk Factors
  • Analysts at JPMorgan Chase & Co. noted that the retirement of CEO Cordani came as a surprise, raising questions about leadership continuity despite their expressed confidence in new CEO Brian Evanko.
  • While Bernstein upgraded the stock, analysts from other firms argue that AI stocks currently offer greater upside potential and carry less downside risk than Cigna (CI).
  • The article suggests that investors looking for short-term gains driven by Trump-era tariffs or onshoring trends should consider AI stocks instead of CI.
  • Despite the 'Outperform' rating and price target increase, the stock is presented as a secondary option compared to emerging AI equities in the current market landscape.
Full Analysis
Bernstein has upgraded The Cigna Group (NYSE:CI) from "Market Perform" to "Outperform," citing several positive catalysts that could drive investor confidence. The upgrade comes alongside slightly raised earnings-per-share (EPS) estimates for the 2027-2030 period, while maintaining the 2026 estimate. Analysts expect the company's stock multiple to increase over time due to key drivers including the Pharmacy Benefit Manager reform bill, the FTC settlement, already announced PBM model changes, and the economic impacts Cigna has guided. The firm set a price target of $358 for the stock. In conjunction with the upgrade, The Cigna Group reiterated its 2026 financial projections on March 3, 2026. Management estimates consolidated adjusted income from operations of at least $30.25 per share. The company also emphasized stability across its major sectors by restating projections for Evernorth's pre-tax adjusted income from operations of at least $6.9 billion and Cigna Healthcare's pre-tax adjusted income from operations of at least $4.5 billion. As a global provider of health services, Cigna offers pharmacy benefit management, specialty pharmacy, care delivery, and medical insurance solutions through its Evernorth Health Services and Cigna Healthcare segments worldwide. Separately, analysts at JPMorgan Chase & Co. commented on the company's recent leadership changes, noting that CEO Cordani's retirement came as a surprise to them. However, they expressed confidence in new leadership under the appointment of CEO Brian Evanko. Earlier reports also noted that The Cigna Group is among the 11 best very cheap stocks to buy according to billionaires. While acknowledging CI's investment potential, the article includes commentary suggesting that certain AI stocks may offer greater upside potential and carry less downside risk. This perspective mentions looking for an extremely undervalued AI stock benefiting from Trump-era tariffs and onshoring trends, directing readers to a free report. The text concludes with a disclosure stating there is none and follows up with links to related articles about stocks that could double in 3 years or make one rich in 10 years.